Dominion Clinical Research

Midlothian, Virginia 23112-3989

0 studies enrolling now · 12 studies all time

What they study most

ADHD, Attention Deficit Hyperactivity Disorder (ADHD), Attention-Deficit/Hyperactivity Disorder, Generalized Anxiety Disorder, Major Depressive Disorder

Studies at this site

• Dose-Optimization Study Evaluating the Efficacy, Safety and Tolerability of Vyvanse (Lisdexamfetamine Dimesylate) in Children Aged 6-12 Diagnosed With ADHD — Completed
• Safety and Efficacy of Vyvanse in Adults With Attention-Deficit/Hyperactivity Disorder — Completed
• Efficacy and Safety of SPD503 in Combination With Psychostimulants — Completed
• Vyvanse Adolescent Open-Label Safety and Efficacy Extension Study — Completed
• SPD503 (Guanfacine Hydrochloride) in ADHD Plus Oppositional Symptoms — Completed
• Efficacy and Safety of Lisdexamfetamine Dimesylate (LDX) in Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD) — Completed
• A One Year Open Label Study Assessing the Safety and Tolerability of Vilazodone in Patients With Major Depressive Disorder (MDD) — Completed
• Study of the Safety and Efficacy of OPC-34712 as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder — Completed
• Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder — Completed
• Study to Assess Satisfaction With Modafinil Treatment in Children and Adolescents With ADHD — Completed
• Comparison of Escitalopram Combination in Adult Patients With Major Depressive Disorder — Completed
• Study of BMS-562086 in the Treatment of Outpatients With Major Depressive Disorder — Completed